2 Biomarkers Found to Predict MS Onset in People with Optic Neuritis
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses two biomarkers found to predict MS onset in people with optic neuritis.Multiple Sclerosis News Today’s columnist, Jessie Ace, talks ab...
29 Mar 202112min
Pipeline Raises $80M to Pursue Potential Myelin Restoring Therapy & The MS Immune System
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how Pipeline raised $80M to pursue potential myelin restoring therapy.Multiple Sclerosis News Today’s multimedia associate, Price Wool...
26 Mar 20219min
Interview With Greg Sonn, A Friend Living With Relapsing-Remitting Multiple Sclerosis
Jenn Powell sits with Greg, a friend with relapsing-remitting multiple sclerosis. Join them as they discuss managing the physical and psychosocial aspects of this disease, as well as the everyday chal...
25 Mar 202134min
Early Life Trauma Affects MS Development in Mice & It’s Important to Quickly Address New MS Symptoms
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how early life trauma affects MS development in mice.Multiple Sclerosis News Today’s columnist, Jessie Ace, describes having a new sym...
24 Mar 20218min
Progressive MS Alliance Wants Changes to Trials to Better Realize Treatments
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how the Progressive MS Alliance wants changes to trials to better realize treatments.Multiple Sclerosis News Today’s columnist, Jessie...
22 Mar 202110min
New Spinal Cord Lesions Can Be Evident in Stable MS Patients & COVID-19 Vaccine With No Side Effects
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how new spinal cord lesions can be evident in stable MS patients.Multiple Sclerosis News Today’s multimedia associate, Price Wooldridg...
19 Mar 202111min
Telemedicine Found Effective During Italy’s COVID-19 Lockdown & I Am Beautifully Rare Despite SPMS
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how telemedicine has been found to be effective during Italy’s Covid-19 lockdown.Multiple Sclerosis News Today’s columnist, Jessie Ace...
17 Mar 20218min
Protein-targeting Therapy Found to Lessen Inflammation in Preclinical Study
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a protein-targeting therapy found to lessen inflammation in preclinical studies.Multiple Sclerosis News Today’s columnist Jessie Ace r...
15 Mar 20219min
